Tourmaline Bio Inc. (TRML)
NASDAQ: TRML
· Real-Time Price · USD
22.50
0.11 (0.49%)
At close: Aug 15, 2025, 3:59 PM
22.13
-1.62%
After-hours: Aug 15, 2025, 05:03 PM EDT
Tourmaline Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.09M | -22.97M | -22.23M | -20.18M | -17.49M | -13.31M | 2.13M | -5.59M | -16.13M | -7.5M | -4.92K | -19.01M | -18.1M | -18.26M | -14.24M | -12.94M | -11.35M | -9.3M |
Depreciation & Amortization | 12K | 12K | 9K | 10K | 10K | 10K | 11K | 9K | 7K | 6K | 5.00 | 596K | 593K | 488K | 188K | 167K | 133K | 135K |
Stock-Based Compensation | 2.47M | 2.27M | 1.74M | 1.68M | 1.79M | 1.39M | 4.25M | 706K | 416.00 | 393.00 | 195.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 1.88M | 80K | 2.18M | -483K | -2.68M | -1.88M | -296K | -487 | 262.00 | 55.00 | 2.4M | -1.65M | -1.46M | 2.1M | 1.8M | -1.64M | -1.27M |
Other Non-Cash Items | 350K | -1.52M | -1.93M | -6.8M | -2.29M | -1.2M | 2.92M | 27K | 8.87M | 32K | 168.00 | 4.04M | 4.73M | 2.42M | 273K | 1.75M | 1.38M | 1.39M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 526K | 1.53M | 1.84M | -33K | -1.81M | 1.71M | -547K | -2.7M | 3.28M | 55.00 | 2.27M | -2.49M | -709K | 3.21M | 1.52M | -1.14M | -1.27M |
Operating Cash Flow | -20.26M | -21.68M | -20.89M | -23.44M | -18.01M | -14.92M | 11.02M | -5.4M | -9.54M | -3.79M | -4.5K | -13.43M | -17.28M | -16.28M | -9.83M | -10.13M | -10.98M | -9.05M |
Capital Expenditures | -7K | -9K | -9K | n/a | n/a | n/a | n/a | -504K | -13K | -24K | -2.29M | -341K | -1.09M | -1.34M | -1.19M | -726K | -335K | -187K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -650K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -40.45M | -85.16M | -19.69M | -88.05M | -42.53M | -215.87M | 68.55M | n/a | -49.36M | -25.27M | -50.99M | -52.6M | -48M | -39.98M | -65.09M | -35.95M | -140.55M | -34.3M |
Sales Maturities Of Investments | 56.76M | 111.11M | 36.09M | 76.35M | 32.4M | 27M | -156.8M | n/a | 58.5M | 53M | 60.27M | 59.25M | 69.02M | 61.75M | 67M | 38.37M | 40.75M | 35.81M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 16.3M | 25.94M | 16.39M | -11.7M | -10.13M | -188.87M | -88.42M | -17K | -13K | -24K | -55 | 6.3M | 19.93M | 20.43M | 721K | 1.69M | -100.13M | 1.33M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -7K | -3K | -1K | n/a | n/a | 5K | n/a | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 54K | n/a | n/a | n/a | n/a | n/a | 85.99M | -3.62M | 92.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -277K | n/a |
Financial Cash Flow | 54K | 562K | -3K | -1K | n/a | 161.35M | 156.46M | -3.62M | 92.2M | 46K | 60K | 73K | 79K | 30K | 412K | -551K | 137.52M | 17K |
Net Cash Flow | -3.91M | 4.82M | -4.5M | -35.14M | -28.14M | -42.44M | 73.87M | 48.73M | 82.65M | -3.81M | -4.55K | -7.05M | 2.73M | 4.18M | -8.7M | -8.99M | n/a | n/a |
Free Cash Flow | -20.27M | -21.69M | -20.9M | -23.44M | -18.01M | -14.92M | 11.02M | -26.27M | -9.55M | -3.81M | -2.3M | -13.77M | -18.37M | -17.62M | -11.02M | -10.86M | -11.32M | -9.23M |